VOYA Investment Management
SIOX

VOYA Investment Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

VOYA Investment Management’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,743
Closed -$19K – 2656
2018
Q1 		$19K Hold
1,743
– – ﹤0.01% 2576
2017
Q4 		$73K Hold
1,743
– – ﹤0.01% 2544
2017
Q3 		$96K Hold
1,743
– – ﹤0.01% 2548
2017
Q2 		$323K Buy
+1,743
New +$306K ﹤0.01% 2111

Other funds holding SIOX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VOYA Investment Management's SIOX Position: Q2 2018 in Review

VOYA Investment Management sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q2 2018, closing a stake of 1,743 shares — an estimated $19K sold.

VOYA Investment Management first reported a position in SIOX in Q2 2017 and held it in 4 quarters. The position peaked at $323K in Q2 2017. 71 funds tracked by Wall St. Rank hold SIOX as of Q2 2018.

  • VOYA Investment Management reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • VOYA Investment Management sold 1,743 Sio Gene Therapies Inc. Common Stock shares in Q2 2018, an estimated $19K.
  • VOYA Investment Management first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2017 and held it in 4 quarters.
  • VOYA Investment Management's Sio Gene Therapies Inc. Common Stock position peaked at $323K in Q2 2017.
  • 71 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q2 2018.

Based on VOYA Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.